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B-cells are the poster child for cellular diversity and heterogeneity. The diverse repertoire
of B lymphocytes, each expressing unique antigen receptors, provides broad protection
against pathogens. However, B-cell diversity goes beyond unique antigen receptors.
Side-stepping B-cell receptor (BCR) diversity through BCR-independent stimuli or
engineered organisms with monoclonal BCRs still results in seemingly identical B-cells
reaching a wide variety of fates in response to the same challenge. Identifying to what
extent the molecular state of a B-cell determines its fate is key to gaining a predictive
understanding of B-cells and consequently the ability to control them with targeted
therapies. Signals received by B-cells through transmembrane receptors converge on
intracellular molecular signaling networks, which control whether each B-cell divides,
dies, or differentiates into a number of antibody-secreting distinct B-cell subtypes.
The signaling networks that interpret these signals are well known to be susceptible
to molecular variability and noise, providing a potential source of diversity in cell fate
decisions. Iterative mathematical modeling and experimental studies have provided
quantitative insight into how B-cells achieve distinct fates in response to pathogenic
stimuli. Here, we review how systems biology modeling of B-cells, and the molecular
signaling networks controlling their fates, is revealing the key determinants of cell-to-cell
variability in B-cell destiny.
Keywords: systems biology, B-cells, computational modeling, heterogeneity, cell signaling, cell fate, NF-κB, cell-
to-cell variability
INTRODUCTION
Following antigen exposure, B-cells are activated, often with the help of T-cells, to secrete antibodies
essential for resolving infections. In addition to this well-studied humoral immune function, an
important role for B-cells in cellular immunity is emerging (Hoffman et al., 2016). B-cell diversity
is vital, with loss of diversity correlating with frailty and reductions in overall survival (Gibson
et al., 2009). Each B-cell’s destiny can range from apoptosis within hours, rapid differentiation into
a short-lived plasma blast in the initial days of an infection (Lam and Baumgarth, 2019), to that of a
memory B-cell surviving for decades (Seifert and Küppers, 2016), or long-lived plasma cells found
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in the bone marrow > 40 years after vaccination (Brynjolfsson
et al., 2017). Even B-cells stimulated ex vivo, without the
complexities of T-cells and the germinal center, will undergo
varied fates (Hawkins et al., 2009; Mitchell et al., 2018). Single-cell
measurements of B-cells, stimulated with B-cell receptor (BCR)-
independent stimuli, show vast cell-to-cell heterogeneity (Shih
et al., 2002; Hawkins et al., 2013). Therefore, it seems that non-
genetic B-cell diversity is an intrinsic property of B-cells. This has
led to substantial efforts to identify the molecular determinants
of B-cell destiny with pivotal studies combining insight from
experimental models with in silico systems biology models. We
will first discuss molecular determinants of each fate decision
in isolation, followed by the molecular signaling pathways that
interpret the cell’s environment. Finally, we will put the pieces
together to describe how cell-to-cell variability in B-cell fates is
understood through systems biology.
CELL CYCLE
In response to antigen challenge, the B-cell population expands
due to a portion of the cell population undergoing repeated
rounds of cell division. In vitro, between 0 and 8 divisions occur,
while multiple rounds of proliferation in the germinal center can
lead to substantially higher (30+) divisions (Duffy et al., 2012; Tas
et al., 2016; Mitchell and Hoffmann, 2018).
Mathematical models have been central to studies of the cell
cycle since the 1960s, starting with phenomenological models
recapitulating cell-cycle phase transitions (Smith and Martin,
1973). Dowling et al. (2014) observed that time spent in both G1
and S/G2/M phases is highly variable in B-cells. As a result, they
proposed an alternative to the highly influential Smith–Martin
model, in which all phases of the cell cycle stretch depending
on a stochastically determined total division time (Smith and
Martin, 1973). The timing of cell-cycle phases was found to
be highly correlated in sister cells, suggesting a pre-existing
non-genetic source of variability strongly inherited through cell
division (Dowling et al., 2014). Interestingly, this stretching of all
cell-cycle phases proportional to total cell-cycle length does not
seem to be maintained in B lymphoma cell lines (Pham et al.,
2018). An inherited molecular source of cell-to-cell variability
is consistent with results from lineage-tracking of division
times across multiple generations in proliferating B lymphocytes
(Duffy et al., 2012; Mitchell et al., 2018). Heinzel et al. (2017)
identified c-Myc as this molecule and fit a mathematical model
to experimental data based on distributed c-Myc controlling
a distributed division destiny. B-cell-specific modeling of cell
division has been restricted to phenomenological modeling
without explicitly representing molecular processes (Callard and
Hodgkin, 2007; Zilman et al., 2010).
Kinetic modeling of the eukaryotic cell cycle became possible
as increasing molecular mechanistic detail was revealed in
the 1990s (Novak and Tyson, 1993; Csikasz-Nagy, 2009). The
foundations for this progress was provided by the seminal
work of Novák and Tyson, whose models have a striking
ability to generate predictions validated many years later
by experiments (Pomerening et al., 2003; Sha et al., 2003;
Novák and Tyson, 2004). By adapting metabolic control analysis
approaches to this model of the cell cycle, Conradie et al.
(2010) found that variation in Cdk2 and its interactions with
cyclin-dependent kinase inhibitor (p27Kip1) and CyclinE were
the most likely sources of cell-to-cell variability in the cell
cycle. Later, live-cell Cdk2 tracking identified a bifurcation in
Cdk2 trajectories, controlled by p27, as a source of cell-to-cell
heterogeneity (Spencer et al., 2013; Figure 1). Despite the fact
that much of this mechanistic insight has been generated from
models of non-lymphatic cell lines, the ability of mechanistic cell-
cycle models to generate insights into multiple model organisms
from yeast to xenopus suggests that the molecular architecture
of such models can also be informative in B-cells (Pomerening
et al., 2005; Skotheim et al., 2008). Indeed, a generic model of the
mammalian cell cycle was incorporated into a multiscale B-cell
model by Shokhirev et al. (2015), which replicated single-cell
B-cell proliferation measured by time-lapse microscopy.
CELL DEATH
Mounting an antibody response requires a balance of B-cell
proliferation and cell death. Inadequate apoptosis leads to
auto-immunity and malignancies while excess apoptosis can
cause immunodeficiency (Cossu, 2010; Correia et al., 2015;
Li et al., 2016; Yang et al., 2016). Mathematical models
have been widely used to illuminate the cell-to-cell variation
in the timing of apoptosis (Spencer and Sorger, 2011).
The first kinetic models of apoptosis were published two
decades ago (Fussenegger et al., 2000), as single-cell analysis
revealed switch-like effector caspase kinetics in individual cells
(Goldstein et al., 2000; Tyas et al., 2000). This switch-like
behavior motivated construction of computational models, with
multiple mechanisms being proposed from receptor clustering
to cooperativity in apoptosome formation or pore formation
(Eissing et al., 2004; Hua et al., 2005; Bagci et al., 2006;
Legewie et al., 2006; Ho and Harrington, 2010). Comprehensive
mechanistic models constructed by Peter Sorger’s group,
combined with single-cell fate tracking, have been instrumental
in understanding cell-to-cell variability in apoptosis (Albeck
et al., 2008; Spencer et al., 2009). These studies attributed
variability in cell death timings to differences in BID truncation
and a threshold determined by the Bcl-2 family proteins (Spencer
et al., 2009; Figure 1). Apoptosis timing was found to be
correlated in recently divided cells, but correlations between
sister cells were lost quickly following cell division (t1/2 = 1.5 h)
due to intrinsic gene expression noise (Spencer et al., 2009).
Similar analysis in B-cells found similar transient correlations
in sibling cell apoptosis timing (Hawkins et al., 2009). This
may seem inconsistent with results showing that, in proliferating
B-cells, the majority of cells that are progeny of a single founder
cell will undergo apoptosis in the same generation, even following
100+ hours of proliferation (Hawkins et al., 2009; Mitchell et al.,
2018). It seems that the cell-to-cell variability in the decision
to undergo apoptosis in a particular generation, and the precise
timing of apoptosis, have distinct sources. This is consistent
with an analysis of the Albeck et al. (2008) model performed by
Frontiers in Cell and Developmental Biology | www.frontiersin.org 2 January 2021 | Volume 8 | Article 616592
fcell-08-616592 January 7, 2021 Time: 12:25 # 3
Mitchell Systems Biology of B-Cell Fate
FIGURE 1 | Overview of key molecular determinants of B-cell fate decisions. Schematic of B-cell fate decisions determined by molecular networks controlling
NF-κB, Apoptosis, differentiation, and the cell cycle. Key molecular determinants of cell-to-cell variability in B-cell fate decisions, identified through systems biology
modeling and experimental studies, are indicated (F).
Loriaux et al. (2013), which found that molecular determinants
of the timing of apoptosis are not equivalent to molecular
determinants of whether or not a cell undergoes apoptosis. This
analysis suggests that Procaspase 8 and its negative regulator
Bar are key determinants of cell-to-cell differences in apoptotic
decision making (Loriaux et al., 2013). Recent Luria–Delbrück
analysis of gene expression revealed that the set of genes
whose expression is reliably inherited differs between cell types
(Luria and Delbrück, 1943; Shaffer et al., 2020). Therefore,
key to predictive mechanistic modeling of B-cell apoptosis
will be understanding the molecular determinants of apoptotic
decisions, along with how reliably these factors are inherited
during proliferation.
B-CELL DIFFERENTIATION
Following proliferation, activated B-cells differentiate into short-
lived plasma blasts or long-lived plasma cells, both of which
are antibody-secreting cells (ASCs) (Shapiro-Shelef and Calame,
2005). Cell division is required but not sufficient for ASC
production, and considerable cell-to-cell differences in the timing
of differentiation following activation exist, even in vitro (Tangye
and Hodgkin, 2004; Zhou et al., 2018).
Recent single-cell RNAseq data indicate a bifurcation during
the early stages of B-cell activation, committing a portion of
cells to an ASC destiny (Scharer et al., 2020). This requires
Interferon Regulatory Factor 4 (IRF4) induction, with higher and
sustained activation biasing cells toward ASC fates (Ochiai et al.,
2013). This was also seen by Xu et al. (2015) who constructed
a minimal mathematical model of mutual inhibition between
IRF4 and IRF8 in B-cells, with initial conditions obtained by flow
cytometry, and found bifurcating fates recreating experiments
showing a fraction of cells undergo rapid differentiation into
plasma blasts. Sciammas et al. (2011) modeled the core regulatory
network controlling terminal differentiation of activated B-cells
including the mutual inhibition between Blimp1 and Bcl6/Bach2,
along with the incoherent effects of IRF4 activating both somatic
hypermutation (through AID) and differentiation (through
Blimp1). This molecular model was incorporated into multiscale
stochastic simulations, which revealed that differences in the
time spent undergoing class-switch recombination and somatic
hypermutation could be explained by the initial rate of IRF4
activation (Sciammas et al., 2011). Subsequent kinetic modeling
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found that interactions between Irf4, Bcl6, and Blimp1 were
sufficient to capture a broad variety of B-cell differentiation
dynamics (Martínez et al., 2012). Taken together, these results
show that cell-to-cell differences in terminal differentiation of
B-cells result from differences in IRF4 signaling.
NF-κB
NF-κB is a dimeric transcription factor, first discovered in
B-cells and later revealed to have near-ubiquitous expression
(Sen and Baltimore, 1986; William et al., 1995; Xu et al.,
1996; Inlay et al., 2002; Baltimore, 2009). NF-κB’s important
role in B-cell development, survival, and function has been
widely studied (Vallabhapurapu and Karin, 2009; Gerondakis
and Siebenlist, 2010; Kaileh and Sen, 2012; Heise et al., 2014;
Almaden et al., 2016). In response to increasing BCR activation,
B-cells show a digital all-or-nothing NF-κB response, with
an increasing number of cells responding, rather than each
cell increasing its response, with increasing NF-κB (Shinohara
et al., 2014). The all-or-nothing response suggests the presence
of a positive feedback loop, enabling cells that cross a cell-
specific threshold of activation to invariably achieve maximum
activation. Through iterative computational and experimental
modeling, a positive feedback was identified between TAK1
(MAP3K7) and inhibitor of NF-κB (IκB) kinase-β (IKKβ)
complex, resulting in switch-like single-cell behaviors; disruption
of this feedback results in a more graded response (Shinohara
et al., 2014). These all-or-nothing responses are consistent with
studies applying information theoretic approaches to NF-κB
signaling, which reveal that intrinsic noise in NF-κB limits
the information the pathway can encode about each cell’s
environment to only a few states, e.g., absence, low and
high stimuli (Cheong et al., 2011; Selimkhanov et al., 2014;
Mitchell and Hoffmann, 2018). It seems unlikely that the
intricate environmental stimuli received by B-cells through
diverse receptors can be accurately encoded through noisy NF-
κB signaling in single cells (Rawlings et al., 2012). This may be
reconciled by a model-aided analysis that revealed a trade-off
between reliable single-cell responses and reliable population-
scale responses, with distributed switch-like responses enabling
an appropriate fraction of cells within a population to reliably
respond (Suderman et al., 2017).
Core to NF-κB signaling is its regulation through
sequestration in the cytoplasm by inhibitory proteins (IκBs)
(Mitchell et al., 2016). IκBs are themselves induced by nuclear
NF-κB, resulting in a negative feedback in which NF-κB inhibits
itself with a delay due to gene expression and protein synthesis
(Figure 1). Such systems can create the oscillatory dynamics
seen in NF-κB signaling, and mathematical modeling has
been central to understanding NF-κB (Hoffmann et al., 2002;
Lipniacki et al., 2004; Nelson et al., 2004; Basak et al., 2012).
Each IκB family member has distinct kinetics of induction,
degradation, and NF-κB sequestration, resulting in distinct
contributions to cell-to-cell variability. IκBα displays rapid
and robust stimulus-dependent degradation and subsequent
NF-κB-dependent induction, creating a noise-insensitive first
peak of NF-κB activity. IκBε has slower kinetics than IκBα
(Kearns et al., 2006). Incorporating IκBε with slower negative
feedback into mathematical simulations revealed that IκBε
enables a more reliable dose-dependent response to sustained
signals, minimizing the impact of stochastic gene expression on
late-phase NF-κB activity (Longo et al., 2013). Through both
kinetic modeling and experimental investigation, IκBε has been
found to limit B-cell expansion through limiting NF-κB cRel and
RelA (Alves et al., 2014).
Whether cell-to-cell differences in NF-κB signaling result
from intrinsically generated noise, such as transcriptional noise,
or pre-existing differences between B-cells prior to stimulation
has been debated (Williams et al., 2014). Both sources of
variation have been simulated through mathematical modeling
of NF-κB, with intrinsic noise recreated through stochastic
simulation using the Gillespie algorithm (Gillespie, 1977) and
pre-existing variability simulated by sampling parameters prior to
deterministic simulations (Hayot and Jayaprakash, 2006; Cheng
et al., 2015; Hughey et al., 2015). Recent studies combining
mathematical modeling with single-cell analysis find that pre-
existing cell-to-cell differences best explain distributed single-cell
NF-κB dynamics and the similar responses observed in daughter
cells (Cheng et al., 2015; Hughey et al., 2015).
PUTTING THE PIECES TOGETHER
In studying the regulatory networks controlling the B-cell fate
decisions described above, a pattern emerges. Key molecular
determinants of cell-to-cell variability in B-cell fate decisions are
NF-κB target genes. Indeed, recent single-cell RNA-sequencing
analysis found that the most highly variable genes in lymphoid
cells were functionally significant and centered around NF-κB
and its target genes, including NFKBIA, MYC, IRF4, and AID
(Osorio et al., 2020).
Myc and Bcl2 are NF-κB target genes that have been
shown to control B-cell division and apoptosis (Duyao et al.,
1990; Chen et al., 1999; Catz and Johnson, 2001; Figure 1).
This was used by Shokhirev et al. (2015) in order to
connect models of NF-κB signaling, the cell cycle, and
apoptosis networks discussed above, recapitulating cellular
statistics from single-cell time-lapse microscopy and revealing
that NF-κB cRel was essential to protect growing B-cells
from apoptosis. Mitchell et al. (2018) used this model to
determine the source of cell-to-cell variability using single-
cell lineage tracking experiments and discovered that B-cell
fates were determined by molecular differences in the naïve
B-cell population that are reliably inherited during proliferation.
Interestingly, predictions of the most significant molecular
determinants of cell-to-cell fate variability depend on the
magnitude of variability. Perturbing parameters controlling NF-
κB signaling resulted in the largest changes in B-cell proliferation;
however, this required relatively large parameter changes of
twofold or more. Smaller changes in parameters, and logistic
regression on simulated cell populations with experimentally
determined molecular heterogeneity, did not identify NF-κB-
related biochemical processes as the largest determinants of
Frontiers in Cell and Developmental Biology | www.frontiersin.org 4 January 2021 | Volume 8 | Article 616592
fcell-08-616592 January 7, 2021 Time: 12:25 # 5
Mitchell Systems Biology of B-Cell Fate
cell-to-cell variability in B-cell proliferation. Instead, apoptotic
signaling regulators such as Bar, Caspase 3, and XIAP were
predicted to be the most significant determinants of B-cell
proliferative outcome, a result tested through caspase inhibition
(Mitchell et al., 2018).
Key determinants of cell-to-cell variability in B-cell terminal
differentiation including Blimp1 and IRF4 are also NF-κB target
genes (Grumont and Gerondakis, 2000; Morgan et al., 2009;
Heise et al., 2014). This led Roy et al. (2019) to add NF-κB
regulation to the model of Sciammas et al. (2011) and discover
that a previously unidentified regulatory interaction was required
to recapitulate experimental results. Roy et al. (2019) discovered
that the missing interaction was transcriptional inhibition of
NF-κB cRel by Blimp1 and that dynamic downregulation of
cRel by Blimp1 was required for plasma cell differentiation
(Roy et al., 2019). Once this new regulatory interaction was
incorporated into the multiscale model of Shokhirev et al.
(2015), the model recapitulated cell-to-cell variability in B-cell
proliferation and differentiation dynamics from wild-type and
knockout mice (Roy et al., 2019). Given the overlap between NF-
κB target genes and key determinants of B-cell fate decisions, well
characterized cell-to-cell variability in NF-κB may coordinate
diverse B-cell fates. Indeed, if Blimp1 upregulation time is noted
in simulations from Roy et al. (2019), this model predicts
that B-cells with the highest NF-κB RelA differentiate more
quickly (Figure 2). As NF-κB integrates BCR and toll-like
receptor signaling and induces IRF4, this prediction is consistent
with the rapid differentiation by high-affinity BCR-expressing
B-cells into plasma blasts (Paus et al., 2006) and the rapidly
differentiating subset of cells with high IRF4 activation (Xu
et al., 2015). Subsequent cRel downregulation is required to
complete differentiation (Roy et al., 2019). The distinct roles
of NF-κB cRel and RelA in B-cell survival and differentiation,
respectively, seen in these multiscale models are consistent
with in vivo requirements for germinal center maintenance and
plasma cell generation (Heise et al., 2014) and an emerging
FIGURE 2 | Multiscale modeling of B-cell fates predicts cell-to-cell variability in NF-κB subunits that can orchestrate distinct fates. (A) Time course of NF-κB RelA
(top) and NF-κB cRel (bottom) from multiscale simulation data from Mitchell et al. (2018). Blimp-1 upregulation time is indicated (◦). Activated B-cells (blue), high
Blimp1 (pink), and high Blimp1 with low AID (complete differentiation, red). (B) Proposed orchestration of cell fates through NF-κB. Inadequate NF-κB induction
results in apoptosis (top). High RelA induction followed and subsequent dynamic cRel downregulation results in rapid plasma blast differentiation. High cRel with
lower RelA (and therefore lower IRF4) results in a proliferative/germinal center phenotype.
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picture of subunit-specific dysregulation of NF-κB in lymphoid
malignancies (Kennedy and Klein, 2018).
DISCUSSION
The decision each B-cell faces, between proliferation, apoptosis,
and differentiation, is vitally important to thread the needle
between autoimmunity and immunodeficiency. An effective
immune response requires a portion of B-cells to rapidly
express antibodies, in order to buy time for the germinal center
reaction to iteratively refine and expand an antigen-specific B-cell
population to resolve the infection. Not only does this require
careful coordination of multiple cell fates within each B-cell,
but it requires cells to reach distinct decisions to the same
challenge. Mathematical modeling provides unique opportunities
to quantitatively disentangle the cell-intrinsic and extrinsic
sources of cell-to-cell variability. Through combined modeling
and single-cell experiments, we now know that distinct B-cell
fates are achieved through molecular differences in the founder
cell of each lineage, which are reliably inherited across many
rounds of cell division (Hawkins et al., 2009; Mitchell et al., 2018).
B-cell differentiation takes place in the germinal centers of
the spleen and lymph nodes. These structures spatially organize
and traffic B-cells, enabling interactions with antigen-presenting
cells and T-cells (De Silva and Klein, 2015; Mesin et al., 2016).
Recently, these extra- and intercellular processes have been
modeled through stochastic approaches (Thomas et al., 2019;
Pélissier et al., 2020). Integrating the molecular determinants of
B-cell fate decision into models of B-cell fates within the germinal
center will be informative for therapeutic targeting of B-cells
(Kepler and Perelson, 1993; Figge, 2005; Meyer-Hermann et al.,
2012; Robert et al., 2017; Thomas et al., 2019; Pélissier et al., 2020;
Verheijen et al., 2020).
The ultimate goal of many of the studies discussed here,
and systems biology as a whole, is to use models to enable
predictive control over cells in health and disease. While
the emerging picture from experiments and models is that
measuring one or even 5+ (Mitchell et al., 2018) molecular
abundances is unlikely to reliably predict a B-cell’s fate, this
does not preclude reliable interventions. Modeling has identified
molecular targets to control B-cell fates and predicted how
mutations will skew proportions and timings of cell fate decisions
in experimental systems (Mitchell et al., 2018; Roy et al., 2019).
One challenge to predictive modeling is that many models
have been parameterized in other cell types, and B-cell specific
parameterization is daunting. However, the prevalence of single-
cell data, along with promising model-generated experiment-
validated results, suggests that a systems biology approach to
predictably controlling B-cell responses is a realistic goal.
AUTHOR CONTRIBUTIONS
SM conceived the study and wrote the manuscript.
FUNDING
This work was funded by Leukaemia UK John Goldman
Fellowship (2020/JGF/003) and Beat: Cancer Research Grant.
ACKNOWLEDGMENTS
We thank Alexander Hoffman, Koushik Roy, and Haripriya
Vaidehi Narayanan for insightful discussion of the topic and
many useful comments on the manuscript.
REFERENCES
Albeck, J. G., Burke, J. M., Spencer, S. L., Lauffenburger, D. A., and Sorger, P. K.
(2008). Modeling a snap-action, variable-delay switch controlling extrinsic cell
death. PLoS Biol. 6:e299. doi: 10.1371/journal.pbio.0060299
Almaden, J. V., Liu, Y. C., Yang, E., Otero, D. C., Birnbaum, H., Davis-Turak, J.,
et al. (2016). B-cell survival and development controlled by the coordination
of NF-κB family members RelB and cRel. Blood J. Am. Soc. Hematol. 127,
1276–1286. doi: 10.1182/blood-2014-10-606988
Alves, B. N., Tsui, R., Almaden, J., Shokhirev, M. N., Davis-Turak, J., Fujimoto, J.,
et al. (2014). IκBε is a key regulator of B cell expansion by providing negative
feedback on cRel and RelA in a stimulus-specific manner. J. Immunol. 192,
3121–3132. doi: 10.4049/jimmunol.1302351
Bagci, E., Vodovotz, Y., Billiar, T., Ermentrout, G., and Bahar, I. (2006). Bistability
in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition
pores. Biophys. J. 90, 1546–1559. doi: 10.1529/biophysj.105.068122
Baltimore, D. (2009). Discovering NF-κB. Cold Spring Harbor Perspect. Biol.
1:a000026. doi: 10.1101/cshperspect.a000026
Basak, S., Behar, M., and Hoffmann, A. (2012). Lessons from mathematically
modeling the NF-κB pathway. Immunol. Rev. 246, 221–238. doi: 10.1111/j.
1600-065x.2011.01092.x
Brynjolfsson, S. F., Mohaddes, M., Kärrholm, J., and Wick, M.-J. (2017). Long-lived
plasma cells in human bone marrow can be either CD19+ or CD19–. Blood Adv.
1:835. doi: 10.1182/bloodadvances.2017004481
Callard, R., and Hodgkin, P. (2007). Modeling T-and B-cell growth and
differentiation. Immunol. Rev. 216, 119–129.
Catz, S. D., and Johnson, J. L. (2001). Transcriptional regulation of bcl-2 by nuclear
factor κB and its significance in prostate cancer. Oncogene 20, 7342–7351.
doi: 10.1038/sj.onc.1204926
Chen, F., Demers, L. M., Vallyathan, V., Lu, Y., Castranova, V., and Shi, X. (1999).
Involvement of 5′-Flanking κB-like Sites withinbcl-x Gene in Silica-induced
Bcl-x Expression. J. Biol. Chem. 274, 35591–35595. doi: 10.1074/jbc.274.50.
35591
Cheng, Z., Taylor, B., Ourthiague, D. R., and Hoffmann, A. (2015). Distinct single-
cell signaling characteristics are conferred by the MyD88 and TRIF pathways
during TLR4 activation. Sci. Signal. 8:ra69. doi: 10.1126/scisignal.aaa5208
Cheong, R., Rhee, A., Wang, C. J., Nemenman, I., and Levchenko, A. (2011).
Information transduction capacity of noisy biochemical signaling networks.
Science 334, 354–358. doi: 10.1126/science.1204553
Conradie, R., Bruggeman, F. J., Ciliberto, A., Csikász-Nagy, A., Novák, B.,
Westerhoff, H. V., et al. (2010). Restriction point control of the mammalian cell
cycle via the cyclin E/Cdk2: p27 complex. FEBS J. 277, 357–367. doi: 10.1111/j.
1742-4658.2009.07473.x
Correia, C., Schneider, P. A., Dai, H., Dogan, A., Maurer, M. J., Church, A. K., et al.
(2015). BCL2 mutations are associated with increased risk of transformation
and shortened survival in follicular lymphoma. Blood J. Am. Soc. Hematol. 125,
658–667. doi: 10.1182/blood-2014-04-571786
Cossu, F. (2010). Genetics of SCID. Italian J. Pediatr. 36:76.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 6 January 2021 | Volume 8 | Article 616592
fcell-08-616592 January 7, 2021 Time: 12:25 # 7
Mitchell Systems Biology of B-Cell Fate
Csikasz-Nagy, A. (2009). Computational systems biology of the cell cycle. Briefings
Bioinform. 10, 424–434. doi: 10.1093/bib/bbp005
De Silva, N. S., and Klein, U. (2015). Dynamics of B cells in germinal centres. Nat.
Rev. Immunol. 15, 137–148. doi: 10.1038/nri3804
Dowling, M. R., Kan, A., Heinzel, S., Zhou, J. H., Marchingo, J. M., Wellard, C. J.,
et al. (2014). Stretched cell cycle model for proliferating lymphocytes. Proceed.
Natl. Acad. Sci. 111, 6377–6382. doi: 10.1073/pnas.1322420111
Duffy, K. R., Wellard, C. J., Markham, J. F., Zhou, J. H., Holmberg, R., Hawkins,
E. D., et al. (2012). Activation-induced B cell fates are selected by intracellular
stochastic competition. Science 335, 338–341. doi: 10.1126/science.1213230
Duyao, M. P., Buckler, A. J., and Sonenshein, G. E. (1990). Interaction of an NF-
kappa B-like factor with a site upstream of the c-myc promoter. Proc. Natl.
Acad. Sci. U S A. 87, 4727–4731. doi: 10.1073/pnas.87.12.4727
Eissing, T., Conzelmann, H., Gilles, E. D., Allgöwer, F., Bullinger, E., and Scheurich,
P. (2004). Bistability analyses of a caspase activation model for receptor-induced
apoptosis. J. Biol. Chem. 279, 36892–36897. doi: 10.1074/jbc.m404893200
Figge, M. T. (2005). Stochastic discrete event simulation of germinal center
reactions. Phys. Rev. E 71:051907.
Fussenegger, M., Bailey, J. E., and Varner, J. (2000). A mathematical model of
caspase function in apoptosis. Nat. Biotechnol. 18, 768–774. doi: 10.1038/77589
Gerondakis, S., and Siebenlist, U. (2010). Roles of the NF-κB pathway in
lymphocyte development and function. Cold Spring Harbor Perspect. Biol.
2:a000182. doi: 10.1101/cshperspect.a000182
Gibson, K. L., Wu, Y. C., Barnett, Y., Duggan, O., Vaughan, R., Kondeatis, E., et al.
(2009). B-cell diversity decreases in old age and is correlated with poor health
status. Aging Cell 8, 18–25. doi: 10.1111/j.1474-9726.2008.00443.x
Gillespie, D. T. (1977). Exact stochastic simulation of coupled chemical reactions.
J. Phys. Chem. 81, 2340–2361. doi: 10.1021/j100540a008
Goldstein, J. C., Waterhouse, N. J., Juin, P., Evan, G. I., and Green, D. R. (2000).
The coordinate release of cytochrome c during apoptosis is rapid, complete and
kinetically invariant. Nat. Cell Biol. 2, 156–162. doi: 10.1038/35004029
Grumont, R. J., and Gerondakis, S. (2000). Rel induces interferon regulatory factor
4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene
expression by rel/nuclear factor κB. J. Exp. Med. 191, 1281–1292. doi: 10.1084/
jem.191.8.1281
Hawkins, E., Markham, J., Mcguinness, L., and Hodgkin, P. (2009). A single-cell
pedigree analysis of alternative stochastic lymphocyte fates. Proc. Natl. Acad.
Sci. 106, 13457–13462. doi: 10.1073/pnas.0905629106
Hawkins, E., Turner, M., Wellard, C., Zhou, J., Dowling, M., and Hodgkin,
P. (2013). Quantal and graded stimulation of B lymphocytes as alternative
strategies for regulating adaptive immune responses. Nat. Commun. 4:2406.
Hayot, F., and Jayaprakash, C. (2006). NF-κB oscillations and cell-to-cell variability.
J. Theoret. Biol. 240, 583–591. doi: 10.1016/j.jtbi.2005.10.018
Heinzel, S., Giang, T. B., Kan, A., Marchingo, J. M., Lye, B. K., Corcoran, L. M.,
et al. (2017). A Myc-dependent division timer complements a cell-death timer
to regulate T cell and B cell responses. Nat. Immunol. 18, 96–103. doi: 10.1038/
ni.3598
Heise, N., De Silva, N. S., Silva, K., Carette, A., Simonetti, G., Pasparakis, M., et al.
(2014). Germinal center B cell maintenance and differentiation are controlled
by distinct NF-κB transcription factor subunits. J. Exp. Med. 211, 2103–2118.
doi: 10.1084/jem.20132613
Ho, K. L., and Harrington, H. A. (2010). Bistability in apoptosis by receptor
clustering. PLoS Comput. Biol. 6:e1000956. doi: 10.1371/journal.pcbi.1000956
Hoffman, W., Lakkis, F. G., and Chalasani, G. (2016). B cells, antibodies, and more.
Clin. J. Am. Soc. Nephrol. 11, 137–154.
Hoffmann, A., Levchenko, A., Scott, M. L., and Baltimore, D. (2002). The IκB-NF-
κB signaling module: temporal control and selective gene activation. Science
298, 1241–1245. doi: 10.1126/science.1071914
Hua, F., Cornejo, M. G., Cardone, M. H., Stokes, C. L., and Lauffenburger, D. A.
(2005). Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation:
molecular genetic tests of computational model predictions. J. Immunol. 175,
985–995. doi: 10.4049/jimmunol.175.2.985
Hughey, J. J., Gutschow, M. V., Bajar, B. T., and Covert, M. W. (2015). Single-cell
variation leads to population invariance in NF-κB signaling dynamics. Mol. Biol.
Cell 26, 583–590. doi: 10.1091/mbc.e14-08-1267
Inlay, M., Alt, F. W., Baltimore, D., and Xu, Y. (2002). Essential roles of the kappa
light chain intronic enhancer and 3′ enhancer in kappa rearrangement and
demethylation. Nat. Immunol. 3, 463–468. doi: 10.1038/ni790
Kaileh, M., and Sen, R. (2012). NF-κB function in B lymphocytes. Immunol. Rev.
246, 254–271. doi: 10.1111/j.1600-065x.2012.01106.x
Kearns, J. D., Basak, S., Werner, S. L., Huang, C. S., and Hoffmann, A. (2006). IκBε
provides negative feedback to control NF-κB oscillations, signaling dynamics,
and inflammatory gene expression. J. Cell Biol. 173, 659–664. doi: 10.1083/jcb.
200510155
Kennedy, R., and Klein, U. (2018). Aberrant activation of NF-κB signalling in
aggressive lymphoid malignancies. Cells 7:189. doi: 10.3390/cells7110189
Kepler, T. B., and Perelson, A. S. (1993). Cyclic re-entry of germinal center B
cells and the efficiency of affinity maturation. Immunol. Today 14, 412–415.
doi: 10.1016/0167-5699(93)90145-b
Lam, J. H., and Baumgarth, N. (2019). The multifaceted B cell response to influenza
virus. J. Immunol. 202, 351–359. doi: 10.4049/jimmunol.1801208
Legewie, S., Blüthgen, N., and Herzel, H. (2006). Mathematical modeling identifies
inhibitors of apoptosis as mediators of positive feedback and bistability. PLoS
Comput. Biol. 2:e120. doi: 10.1371/journal.pcbi.0020120
Li, Y., Takahashi, Y., Fujii, S.-I., Zhou, Y., Hong, R., Suzuki, A., et al.
(2016). EAF2 mediates germinal centre B-cell apoptosis to suppress
excessive immune responses and prevent autoimmunity. Nat. Commun. 7:
10836.
Lipniacki, T., Paszek, P., Brasier, A. R., Luxon, B., and Kimmel, M. (2004).
Mathematical model of NF-κB regulatory module. J. Theoret. Biol. 228, 195–
215. doi: 10.1016/j.jtbi.2004.01.001
Longo, D. M., Selimkhanov, J., Kearns, J. D., Hasty, J., Hoffmann, A., and Tsimring,
L. S. (2013). Dual delayed feedback provides sensitivity and robustness to the
NF-κ B signaling module. PLoS Comput. Biol. 9:e1003112. doi: 10.1371/journal.
pcbi.1003112
Loriaux, P. M., Tesler, G., and Hoffmann, A. (2013). Characterizing the relationship
between steady state and response using analytical expressions for the steady
states of mass action models. PLoS Comput. Biol. 9:e1002901. doi: 10.1371/
journal.pcbi.1002901
Luria, S. E., and Delbrück, M. (1943). Mutations of bacteria from virus sensitivity
to virus resistance. Genetics 28:491.
Martínez, M. R., Corradin, A., Klein, U., Álvarez, M. J., Toffolo, G. M., Di Camillo,
B., et al. (2012). Quantitative modeling of the terminal differentiation of B
cells and mechanisms of lymphomagenesis. Proc. Natl. Acad. Sci. U S A. 109,
2672–2677. doi: 10.1073/pnas.1113019109
Mesin, L., Ersching, J., and Victora, G. D. (2016). Germinal center B cell dynamics.
Immunity 45, 471–482. doi: 10.1016/j.immuni.2016.09.001
Meyer-Hermann, M., Mohr, E., Pelletier, N., Zhang, Y., Victora, G. D., and Toellner,
K.-M. (2012). A theory of germinal center B cell selection, division, and exit. Cell
Rep. 2, 162–174. doi: 10.1016/j.celrep.2012.05.010
Mitchell, S., and Hoffmann, A. (2018). Identifying noise sources governing cell-
to-cell variability. Curr. Opin. Systems Biol. 8, 39–45. doi: 10.1016/j.coisb.2017.
11.013
Mitchell, S., Roy, K., Zangle, T. A., and Hoffmann, A. (2018). Nongenetic origins
of cell-to-cell variability in B lymphocyte proliferation. Proc. Natl. Acad. Sci. U
S A. 115, E2888–E2897.
Mitchell, S., Vargas, J., and Hoffmann, A. (2016). Signaling via the NFκB system.
Wiley Interdiscip. Rev. Systems Biol. Med. 8, 227–241.
Morgan, M. A., Magnusdottir, E., Kuo, T. C., Tunyaplin, C., Harper, J., Arnold,
S. J., et al. (2009). Blimp-1/Prdm1 alternative promoter usage during mouse
development and plasma cell differentiation. Mol. Cell. Biol. 29, 5813–5827.
doi: 10.1128/mcb.00670-09
Nelson, D. E., Ihekwaba, A. E. C., Elliott, M., Johnson, J. R., Gibney, C. A.,
Foreman, B. E., et al. (2004). Oscillations in NF-κB signaling control the
dynamics of gene expression. Science 306, 704–708. doi: 10.1126/science.10
9996
Novak, B., and Tyson, J. J. (1993). Numerical analysis of a comprehensive model of
M-phase control in xenopus oocyte extracts and intact embryos. J. Cell Sci. 106,
1153–1168.
Novák, B., and Tyson, J. J. (2004). A model for restriction point control of the
mammalian cell cycle. J. Theoret. Biol. 230, 563–579. doi: 10.1016/j.jtbi.2004.
04.039
Ochiai, K., Maienschein-Cline, M., Simonetti, G., Chen, J., Rosenthal, R., Brink,
R., et al. (2013). Transcriptional regulation of germinal center B and plasma
cell fates by dynamical control of IRF4. Immunity 38, 918–929. doi: 10.1016/j.
immuni.2013.04.009
Frontiers in Cell and Developmental Biology | www.frontiersin.org 7 January 2021 | Volume 8 | Article 616592
fcell-08-616592 January 7, 2021 Time: 12:25 # 8
Mitchell Systems Biology of B-Cell Fate
Osorio, D., Yu, X., Zhong, Y., Li, G., Serpedin, E., Huang, J. Z., et al. (2020).
Single-Cell expression variability implies cell function. Cells 9:14. doi: 10.3390/
cells9010014
Paus, D., Phan, T. G., Chan, T. D., Gardam, S., Basten, A., and Brink, R. (2006).
Antigen recognition strength regulates the choice between extrafollicular
plasma cell and germinal center B cell differentiation. J. Exp. Med. 203, 1081–
1091. doi: 10.1084/jem.20060087
Pélissier, A., Akrout, Y., Jahn, K., Kuipers, J., Klein, U., Beerenwinkel,
N., et al. (2020). computational model reveals a stochastic mechanism
behind germinal center clonal bursts. Cells 9:1448. doi: 10.3390/cells906
1448
Pham, K., Kan, A., Whitehead, L., Hennessy, R., Rogers, K., and Hodgkin, P. (2018).
Converse smith-martin cell cycle kinetics by transformed B lymphocytes. Cell
Cycle 17, 2041–2051. doi: 10.1080/15384101.2018.1511511
Pomerening, J. R., Kim, S. Y., and Ferrell, J. E. Jr. (2005). Systems-level dissection
of the cell-cycle oscillator: bypassing positive feedback produces damped
oscillations. Cell 122, 565–578. doi: 10.1016/j.cell.2005.06.016
Pomerening, J. R., Sontag, E. D., and Ferrell, J. E. (2003). Building a cell cycle
oscillator: hysteresis and bistability in the activation of Cdc2. Nat. Cell Biol. 5,
346–351. doi: 10.1038/ncb954
Rawlings, D. J., Schwartz, M. A., Jackson, S. W., and Meyer-Bahlburg, A.
(2012). Integration of B cell responses through Toll-like receptors and antigen
receptors. Nat. Rev. Immunol. 12, 282–294. doi: 10.1038/nri3190
Robert, P. A., Rastogi, A., Binder, S. C., and Meyer-Hermann, M. (2017). “How to
simulate a germinal center,” in Germinal Centers. Methods in Molecular Biology,
ed. D. Calado (New York, NY: Humana Press), 303–334. doi: 10.1007/978-1-
4939-7095-7_22
Roy, K., Mitchell, S., Liu, Y., Ohta, S., Lin, Y.-S., Metzig, M. O., et al. (2019). A
regulatory circuit controlling the dynamics of NFκB cRel transitions B cells
from proliferation to plasma cell differentiation. Immunity 50, 616.–628.
Scharer, C. D., Patterson, D. G., Mi, T., Price, M. J., Hicks, S. L., and Boss, J. M.
(2020). Antibody-secreting cell destiny emerges during the initial stages of
B-cell activation. Nat. Commun. 11:3989.
Sciammas, R., Li, Y., Warmflash, A., Song, Y., Dinner, A. R., and Singh, H.
(2011). An incoherent regulatory network architecture that orchestrates B cell
diversification in response to antigen signaling. Mol. Systems Biol. 7:495. doi:
10.1038/msb.2011.25
Seifert, M., and Küppers, R. (2016). Human memory B cells. Leukemia 30, 2283–
2292.
Selimkhanov, J., Taylor, B., Yao, J., Pilko, A., Albeck, J., Hoffmann, A., et al. (2014).
Accurate information transmission through dynamic biochemical signaling
networks. Science 346, 1370–1373. doi: 10.1126/science.1254933
Sen, R., and Baltimore, D. (1986). Multiple nuclear factors interact with the
immunoglobulin enhancer sequences. Cell 46, 705–716. doi: 10.1016/0092-
8674(86)90346-6
Sha, W., Moore, J., Chen, K., Lassaletta, A. D., Yi, C.-S., Tyson, J. J., et al. (2003).
Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts. Proc. Natl.
Acad. Sci. U S A. 100, 975–980. doi: 10.1073/pnas.0235349100
Shaffer, S. M., Emert, B. L., Hueros, R. A. R., Coté, C., Harmange, G., Schaff, D. L.,
et al. (2020). Memory sequencing reveals heritable single-cell gene expression
programs associated with distinct cellular behaviors. Cell 182, 947–959. doi:
10.1016/j.cell.2020.07.003
Shapiro-Shelef, M., and Calame, K. (2005). Regulation of plasma-cell development.
Nat. Rev. Immunol. 5, 230–242. doi: 10.1038/nri1572
Shih, T.-A. Y., Roederer, M., and Nussenzweig, M. C. (2002). Role of antigen
receptor affinity in T cell–independent antibody responses in vivo. Nat.
Immunol. 3, 399–406. doi: 10.1038/ni776
Shinohara, H., Behar, M., Inoue, K., Hiroshima, M., Yasuda, T., Nagashima, T.,
et al. (2014). Positive feedback within a kinase signaling complex functions as
a switch mechanism for NF-κB activation. Science 344, 760–764. doi: 10.1126/
science.1250020
Shokhirev, M. N., Almaden, J., Davis-Turak, J., Birnbaum, H. A., Russell, T. M.,
Vargas, J. A., et al. (2015). A multi-scale approach reveals that NF-κB cR el
enforces a B-cell decision to divide. Mol. Systems Biol. 11:783. doi: 10.15252/
msb.20145554
Skotheim, J. M., Di Talia, S., Siggia, E. D., and Cross, F. R. (2008). Positive feedback
of G1 cyclins ensures coherent cell cycle entry. Nature 454, 291–296. doi:
10.1038/nature07118
Smith, J., and Martin, L. (1973). Do cells cycle? Proc. Natl. Acad. Sci. U S A. 70,
1263–1267.
Spencer, S. L., Cappell, S. D., Tsai, F.-C., Overton, K. W., Wang, C. L., and Meyer, T.
(2013). The proliferation-quiescence decision is controlled by a bifurcation in
CDK2 activity at mitotic exit. Cell 155, 369–383. doi: 10.1016/j.cell.2013.08.062
Spencer, S. L., Gaudet, S., Albeck, J. G., Burke, J. M., and Sorger, P. K. (2009). Non-
genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature
459, 428–432. doi: 10.1038/nature08012
Spencer, S. L., and Sorger, P. K. (2011). Measuring and modeling apoptosis in single
cells. Cell 144, 926–939. doi: 10.1016/j.cell.2011.03.002
Suderman, R., Bachman, J. A., Smith, A., Sorger, P. K., and Deeds, E. J. (2017).
Fundamental trade-offs between information flow in single cells and cellular
populations. Proc. Natl. Acad. Sci. U S A. 114, 5755–5760. doi: 10.1073/pnas.
1615660114
Tangye, S. G., and Hodgkin, P. D. (2004). Divide and conquer: the importance
of cell division in regulating B-cell responses. Immunology 112, 509–520. doi:
10.1111/j.1365-2567.2004.01950.x
Tas, J. M., Mesin, L., Pasqual, G., Targ, S., Jacobsen, J. T., Mano, Y. M., et al.
(2016). Visualizing antibody affinity maturation in germinal centers. Science
351, 1048–1054. doi: 10.1126/science.aad3439
Thomas, M. J., Klein, U., Lygeros, J., and Rodríguez Martínez, M. (2019). A
probabilistic model of the germinal center reaction. Front. Immunol. 10:689.
doi: 10.3389/fimmu.2019.00689
Tyas, L., Brophy, V. A., Pope, A., Rivett, A. J., and Tavaré, J. M. (2000). Rapid
caspase-3 activation during apoptosis revealed using fluorescence-resonance
energy transfer. EMBO Rep. 1, 266–270. doi: 10.1093/embo-reports/kvd050
Vallabhapurapu, S., and Karin, M. (2009). Regulation and function of NF-κB
transcription factors in the immune system. Ann. Rev. Immunol. 27, 693–733.
doi: 10.1146/annurev.immunol.021908.132641
Verheijen, M., Rane, S., Pearson, C., Yates, A. J., and Seddon, B. (2020).
Fate mapping quantifies the dynamics of B cell development and activation
throughout life. Cell Rep. 33:108376. doi: 10.1016/j.celrep.2020.108376
William, C. S., Liou, H.-C., Tuomanen, E. I., and Baltimore, D. (1995). Targeted
disruption of the p50 subunit of NF-κB leads to multifocal defects in immune
responses. Cell 80, 321–330. doi: 10.1016/0092-8674(95)90415-8
Williams, R. A., Timmis, J., and Qwarnstrom, E. E. (2014). Computational models
of the NF-KB signalling pathway. Computation 2, 131–158. doi: 10.3390/
computation2040131
Xu, H., Chaudhri, V. K., Wu, Z., Biliouris, K., Dienger-Stambaugh, K., Rochman,
Y., et al. (2015). Regulation of bifurcating B cell trajectories by mutual
antagonism between transcription factors IRF4 and IRF8. Nat. Immunol. 16,
1274–1281. doi: 10.1038/ni.3287
Xu, Y., Davidson, L., Alt, F. W., and Baltimore, D. (1996). Deletion of the Ig kappa
light chain intronic enhancer/matrix attachment region impairs but does not
abolish V kappa J kappa rearrangement. Immunity 4, 377–385. doi: 10.1016/
s1074-7613(00)80251-4
Yang, J., Zhao, S., Yang, X., Zhang, H., Zheng, P., and Wu, H. (2016). Inhibition of
B-cell apoptosis is mediated through increased expression of Bcl-2 in patients
with rheumatoid arthritis. Int. J. Rheumat. Dis. 19, 134–140. doi: 10.1111/1756-
185x.12706
Zhou, J. H., Markham, J. F., Duffy, K. R., and Hodgkin, P. D. (2018). Stochastically
timed competition between division and differentiation fates regulates the
transition from B lymphoblast to plasma cell. Front. Immunol. 9:2053. doi:
10.3389/fimmu.2018.02053
Zilman, A., Ganusov, V. V., and Perelson, A. S. (2010). Stochastic models of
lymphocyte proliferation and death. PLoS One 5:e12775. doi: 10.1371/journal.
pone.0012775
Conflict of Interest: The author declares that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Mitchell. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) and the
copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 8 January 2021 | Volume 8 | Article 616592
